{"url":"https://lda.gov/api/v1/filings/830c1b53-d09f-4372-b124-4a28fb10dd55/","filing_uuid":"830c1b53-d09f-4372-b124-4a28fb10dd55","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2025,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/830c1b53-d09f-4372-b124-4a28fb10dd55/print/","filing_document_content_type":"text/html","income":null,"expenses":"2540000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Katie Oppenheim","dt_posted":"2025-04-21T16:04:50-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"1001 PENNSYLVANIA AVENUE NW","registrant_address_2":"SUITE 650N","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":56838,"url":"https://lda.gov/api/v1/registrants/56838/","house_registrant_id":35186,"name":"SANOFI US SERVICES INC.","description":"sanofi-aventis U.S. Inc. discovers, develops, and markets prescription pharmaceuticals","address_1":"1455 PENNSYLVANIA AVENUE NW","address_2":"SUITE 500","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"KATIE OPPENHEIM","contact_telephone":"+1 202-585-3000","dt_updated":"2026-07-30T19:07:40.607412-04:00"},"client":{"id":159929,"url":"https://lda.gov/api/v1/clients/159929/","client_id":12,"name":"SANOFI US SERVICES INC","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-12-11"},"lobbying_activities":[{"general_issue_code":"MAN","general_issue_code_display":"Manufacturing","description":"Drug Pricing - General Issues; Taxes- General Issues; Tax Credits; Insurance Design.","foreign_entity_issues":"Sanofi US Services Inc is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.","lobbyists":[{"lobbyist":{"id":84813,"prefix":null,"prefix_display":null,"first_name":"MORGAN","nickname":null,"middle_name":null,"last_name":"BRADLEY-JONES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67581,"prefix":null,"prefix_display":null,"first_name":"KATIE","nickname":null,"middle_name":null,"last_name":"OPPENHEIM","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"340B: Biologic/Small molecule drug negotiation eligibility within HR 7174/S. 832; EPIC Act; CDC Type 1 Diabetes Awareness and Education: LHHS approps; Clinical Trial Diversity; Copay Accumulators; COPD Education and Awareness: LHHS approps; COPD Research Funding: LHHS approps; Delinking; Drug Price Negotiations; Drug Pricing- General Issues; FDA Drug Development; FDA Issues - General; HR 946- Orphan Drug Negotiation: Orphan Cures Act; HR 1503: Prescription Information Modernization Act of 2023; HR 2880: Protecting Patients Against PBM Abuses Act; HR 5376: Inflation Reduction Act; HR 830: HELP Copays Act; HRSA - Type 1 Diabetes Screening: LHHS approps; Influenza Vaccines; Insulin Pricing-General; Insurance Design; Intellectual Property; Out of Pocket Cap (OOP); Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization; Pharmacy Benefit Managers (PBM) Reform; Rare Pediatric Priority Review Voucher Program Reauthorization within HR 1262/ S. 932: Give Kids a Chance Act; Rebate Pass Through; Respiratory Syncytial Virus (RSV) Access; Routine Immunization Rates; S. 1339: PBM Reform Act; S. 864: HELP Copays Act; S. 1542: DRUG Act; S. 2916: Prescription Information Modernization Act of 2023; S.4504 / HR 8698 (118th): SCREEN for Type 1 Diabetes Act; Supply Chain; Tax Credits; Transplant; Type 1 Diabetes Screening; Vaccine Injury Compensation Program; Vaccines-General Issues.","foreign_entity_issues":"Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.","lobbyists":[{"lobbyist":{"id":67581,"prefix":null,"prefix_display":null,"first_name":"KATIE","nickname":null,"middle_name":null,"last_name":"OPPENHEIM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":84813,"prefix":null,"prefix_display":null,"first_name":"MORGAN","nickname":null,"middle_name":null,"last_name":"BRADLEY-JONES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139849,"prefix":"ms","prefix_display":"MS.","first_name":"CLAIRE","nickname":null,"middle_name":"WILLIS","last_name":"BRANDEWIE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139729,"prefix":"ms","prefix_display":"MS.","first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"DALE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149745,"prefix":null,"prefix_display":null,"first_name":"EMILY","nickname":null,"middle_name":null,"last_name":"MICHAEL","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"340B; Medicaid Drug Rebate Program Rule; Medicare Negotiation.","foreign_entity_issues":"Sanofi US Services Inc is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.","lobbyists":[{"lobbyist":{"id":67581,"prefix":null,"prefix_display":null,"first_name":"KATIE","nickname":null,"middle_name":null,"last_name":"OPPENHEIM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139729,"prefix":"ms","prefix_display":"MS.","first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"DALE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139849,"prefix":"ms","prefix_display":"MS.","first_name":"CLAIRE","nickname":null,"middle_name":"WILLIS","last_name":"BRANDEWIE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149745,"prefix":null,"prefix_display":null,"first_name":"EMILY","nickname":null,"middle_name":null,"last_name":"MICHAEL","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Insulin; Supply Chain Issues.","foreign_entity_issues":"Sanofi US Services Inc is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.","lobbyists":[{"lobbyist":{"id":67581,"prefix":null,"prefix_display":null,"first_name":"KATIE","nickname":null,"middle_name":null,"last_name":"OPPENHEIM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":84813,"prefix":null,"prefix_display":null,"first_name":"MORGAN","nickname":null,"middle_name":null,"last_name":"BRADLEY-JONES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139729,"prefix":"ms","prefix_display":"MS.","first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"DALE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149745,"prefix":null,"prefix_display":null,"first_name":"EMILY","nickname":null,"middle_name":null,"last_name":"MICHAEL","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Pharmacy Benefits Managers (PBMs); Supply Chain; Taxes-General Issues; TCJA Expiration - Tax Cuts and Jobs Act; Transplant; Vaccine Injury Compensation Program.","foreign_entity_issues":"Sanofi US Services Inc is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.","lobbyists":[{"lobbyist":{"id":84813,"prefix":null,"prefix_display":null,"first_name":"MORGAN","nickname":null,"middle_name":null,"last_name":"BRADLEY-JONES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67581,"prefix":null,"prefix_display":null,"first_name":"KATIE","nickname":null,"middle_name":null,"last_name":"OPPENHEIM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139849,"prefix":"ms","prefix_display":"MS.","first_name":"CLAIRE","nickname":null,"middle_name":"WILLIS","last_name":"BRANDEWIE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139729,"prefix":"ms","prefix_display":"MS.","first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"DALE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149745,"prefix":null,"prefix_display":null,"first_name":"EMILY","nickname":null,"middle_name":null,"last_name":"MICHAEL","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"Intellectual Property.","foreign_entity_issues":"Sanofi US Services Inc is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.","lobbyists":[{"lobbyist":{"id":139849,"prefix":"ms","prefix_display":"MS.","first_name":"CLAIRE","nickname":null,"middle_name":"WILLIS","last_name":"BRANDEWIE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67581,"prefix":null,"prefix_display":null,"first_name":"KATIE","nickname":null,"middle_name":null,"last_name":"OPPENHEIM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139729,"prefix":"ms","prefix_display":"MS.","first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"DALE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149745,"prefix":null,"prefix_display":null,"first_name":"EMILY","nickname":null,"middle_name":null,"last_name":"MICHAEL","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}